SCHEMBL29845682

SCHEMBL29845682

CC(=O)Nc1cc(Oc2ccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)n4c3c2CCC4)ccn1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRAF P15056 18/20 0.51
KDR P35968 13/20 0.51
RAF1 P04049 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23166490 1.00 BRAF (0.51) BRAFKDRRAF1
SCHEMBL23166538 0.88 BRAF (0.56) BRAFKDRRAF1
SCHEMBL29845507 0.88 BRAF (0.56) BRAFKDRRAF1
SCHEMBL23205579 0.86 ABL1 (0.52) BRAFKDRRAF1
SCHEMBL29845647 0.84 BRAF (0.43) BRAFKDRRAF1
SCHEMBL23166690 0.84 BRAF (0.43) BRAFKDRRAF1
SCHEMBL30313590 0.83 BRAF (0.57) BRAFKDRRAF1
SCHEMBL24007226 0.83 BRAF (0.57) BRAFKDRRAF1
SCHEMBL23167163 0.82 BRAF (0.51) BRAFKDR
SCHEMBL29845577 0.82 BRAF (0.51) BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041236-A1 TRICYCLIC KINASE INHIBITORS AND USES THEREOF Dana-Farber Cancer Institute, Inc. (US) 2022-08-17 EP disclosed